Literature DB >> 34010836

Stroke and Heart Attack Symptom Recognition in Older US Adults by Cognitive Impairment Status.

Phoebe Tran1, Lam Tran2.   

Abstract

INTRODUCTION: Cognitive impairment may make stroke and heart attack symptom recognition difficult, potentially resulting in treatment delays for those with these cardiovascular diseases (CVDs). Despite cognitive impairment affecting large numbers of older US adults who are also at increased risk of stroke and heart attack, little is known about stroke and heart attack symptom recognition in this population. As a result, this study sought to determine the impact of cognitive impairment on stroke and heart attack symptom recognition among older US adults.
METHODS: Using the 2014 and 2017 National Health Interview Surveys, we compared stroke and heart attack symptom recognition levels in US adults aged ≥65 years with cognitive impairment and those without cognitive impairment. Estimates of stroke and heart attack symptom recognition adjusted for CVD-related factors were assessed by cognitive impairment status. We also conducted analyses stratified by living arrangement and stroke and heart attack history for individuals with and without cognitive impairment.
RESULTS: US adults aged ≥65 years with cognitive impairment were observed to be 3.0-6.7% and 1.6-4.9%, respectively, less likely to recognize an individual stroke and heart attack symptom than similarly aged individuals without cognitive impairment. Recognition of all 5 stroke/heart attack symptoms was also lower among those with cognitive impairment, with this group being 9.7% less likely to recognize all stroke symptoms and 6.7% less likely to recognize all 5 heart attack symptoms compared to people without cognitive impairment. Following adjustment, individuals with cognitive impairment continued to have slightly lower recognition of certain individual stroke and heart attack symptoms as well as of all 5 symptoms of these conditions (stroke OR: 0.70 [95% CI: 0.58-0.85]; heart attack OR: 0.88 [95% CI: 0.75, 1.03]) than those without cognitive impairment. For individuals with cognitive impairment, living with others was linked with slightly better recognition of all individual stroke symptoms and heart attack history with better recognition of all individual heart attack symptoms.
CONCLUSIONS: Additional work is needed to address the challenge of improving recognition levels for specific stroke and heart attack symptoms in older US adults with cognitive impairment and especially for members of this group who live alone.
© 2021 S. Karger AG, Basel.

Entities:  

Keywords:  Cognitive impairment; Epidemiology; Heart attack; Stroke; Symptom recognition

Mesh:

Year:  2021        PMID: 34010836      PMCID: PMC8217162          DOI: 10.1159/000516343

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  17 in total

1.  On Living Alone with Alzheimer's Disease.

Authors:  E Portacolone
Journal:  Care Wkly       Date:  2018

2.  Assessing measurement error in Medicare coverage from the National Health Interview Survey.

Authors:  Renee Gindi; Robin A Cohen
Journal:  Medicare Medicaid Res Rev       Date:  2012-06-26

3.  Shorter ischaemic time and improved survival with pre-hospital STEMI diagnosis and direct transfer for primary PCI.

Authors:  Ahmad Farshid; Chris Allada; Jaya Chandrasekhar; Paul Marley; Darryl McGill; Simon O'Connor; Moyazur Rahman; Ren Tan; Bruce Shadbolt
Journal:  Heart Lung Circ       Date:  2014-09-30       Impact factor: 2.975

4.  Awareness of heart attack symptoms among US adults in 2007, and changes in awareness from 2001 to 2007.

Authors:  Jing Fang; Cathleen Gillespie; Nora L Keenan; Kurt J Greenlund
Journal:  Future Cardiol       Date:  2011-05

5.  Cognitive impairment and outcomes in older adult survivors of acute myocardial infarction: findings from the translational research investigating underlying disparities in acute myocardial infarction patients' health status registry.

Authors:  S Michael Gharacholou; Kimberly J Reid; Suzanne V Arnold; John Spertus; Michael W Rich; Patricia A Pellikka; Mandeep Singh; Tracey Holsinger; Harlan M Krumholz; Eric D Peterson; Karen P Alexander
Journal:  Am Heart J       Date:  2011-11       Impact factor: 4.749

6.  Benefit From Reperfusion With Primary Percutaneous Coronary Intervention Beyond 12 Hours of Symptom Duration in Patients With ST-Segment-Elevation Myocardial Infarction.

Authors:  Lars Nepper-Christensen; Jacob Lønborg; Dan E Høfsten; Kiril A Ahtarovski; Lia E Bang; Steffen Helqvist; Kasper Kyhl; Lars Køber; Henning Kelbæk; Niels Vejlstrup; Lene Holmvang; Thomas Engstrøm
Journal:  Circ Cardiovasc Interv       Date:  2018-09       Impact factor: 6.546

7.  Estimated prevalence of people with cognitive impairment: results from nationally representative community and institutional surveys.

Authors:  Amy B Bernstein; Robin E Remsburg
Journal:  Gerontologist       Date:  2007-06

8.  Self-Reported Cognitive Impairment Across Racial/Ethnic Groups in the United States, National Health Interview Survey, 1997-2015.

Authors:  Huabin Luo; Gary Yu; Bei Wu
Journal:  Prev Chronic Dis       Date:  2018-01-11       Impact factor: 2.830

9.  Variation and Disparities in Awareness of Myocardial Infarction Symptoms Among Adults in the United States.

Authors:  Shiwani Mahajan; Javier Valero-Elizondo; Rohan Khera; Nihar R Desai; Ron Blankstein; Michael J Blaha; Salim S Virani; Bita A Kash; William A Zoghbi; Harlan M Krumholz; Khurram Nasir
Journal:  JAMA Netw Open       Date:  2019-12-02

10.  Accuracy and usefulness of BMI measures based on self-reported weight and height: findings from the NHANES & NHIS 2001-2006.

Authors:  Manfred Stommel; Charlotte A Schoenborn
Journal:  BMC Public Health       Date:  2009-11-19       Impact factor: 3.295

View more
  1 in total

1.  Symptom Recognition as a Mediator in the Self-Care of Chronic Illness.

Authors:  Barbara Riegel; Maddalena De Maria; Claudio Barbaranelli; Maria Matarese; Davide Ausili; Anna Stromberg; Ercole Vellone; Tiny Jaarsma
Journal:  Front Public Health       Date:  2022-05-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.